News of the WeekClinical Research

Shutdown at Hopkins Sparks a Debate

+ See all authors and affiliations

Science  27 Jul 2001:
Vol. 293, Issue 5530, pp. 587-589
DOI: 10.1126/science.293.5530.587

You are currently viewing the summary.

View Full Text

Summary

The federal government abruptly suspended all U.S.-funded human studies at Johns Hopkins University in Baltimore last week. Then, in a turnabout 3 days later, it allowed about 700 of the more than 2400 that were affected to resume, although with restrictions. The crisis sent a shock through the clinical research world, mainly because Hopkins is regarded as one of the country's most conscientious overseers of research. And it seemed likely to raise questions anew about how best to protect research subjects.